NCT02471820 Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients Status COMPLETED Phase PHASE2
NCT02468700 OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye Status COMPLETED Phase PHASE2
NCT02464657 Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE1/PHASE2
NCT02462525 Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma Status TERMINATED Phase PHASE1
NCT02461888 Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma. Status COMPLETED Phase PHASE2
NCT02450994 Effect of Dexamethasone on Sleep Related Breathing Disturbances in Patients With COPD at Altitude Status COMPLETED Phase PHASE4
NCT02450968 Altitude Related Illness In Patients With Respiratory Disease Status COMPLETED Phase PHASE4
NCT02445872 Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy Status UNKNOWN Phase PHASE2
NCT02445326 OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis Status COMPLETED Phase PHASE3
NCT02441894 Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer Status COMPLETED Phase PHASE4
NCT02441686 Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE2
NCT02436707 Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02436265 Low Dose IV Dexamethasone in Prolonging Caudal Anesthesia in Children Undergoing Genitourinary Surgery Status TERMINATED Phase PHASE4
NCT02433899 Microsurgical Versus Conventional Semilunar Coronally Advanced Flap Status COMPLETED Phase PHASE4
NCT02431208 A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM) Status COMPLETED Phase PHASE1